Cerenome, a CNS oncology company, will report its third quarter 2026 financial results on November 16, 2026, and host a conference call to review clinical data for its REYOBIQ therapeutic and provide a commercial update on its CNSide diagnostics platform. The REYOBIQ data will be presented at the SNO conference on November 13. This event is significant as Cerenome integrates diagnostics, therapeutics, and AI to advance treatment for central nervous system cancers, aiming to improve patient outcomes and shareholder value.
Cerenome's upcoming review of REYOBIQ data and CNSide commercial update provides context for health sector trading. For readers following health stocks, here is Pluang's market snapshot as of Nov 12, 2026 19:11 WIB: of 150 priced US health-sector stocks, 91 rose and 53 fell. Notable movers include AVAH at USD 12.20 with a 1-day change of -6.80% and a typical hold time of 25 days, SANA at USD 2.41 up 5.24% with 94% buy orders and a 26-day hold, and BNGO at USD 1.15 up 4.55% with a 52-day hold and balanced buy-sell activity.
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...
BofA Securities raised its price target for Royal Caribbean Group to $365, citing strong booking volumes and the company’s goal of adjusted earnings per share around $20 by 2027. The cruise operator expects 4.5% capacity growth next year and has repo...
Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...
